CAS # 444731-52-6
Pharma Grade (MW 437.52 g/mol)
Pazopanib Multi-Target TKI API
Pazopanib is an oral multi-target tyrosine kinase inhibitor targeting VEGFR-1/2/3, PDGFR-α/β, and FGFR-1/3 for Advanced Renal Cell Carcinoma (RCC) and Soft Tissue Sarcoma (STS).
Assay / Purity
≥ 98.5% (C21H23N7O2S)
Physical Appearance
White to Slightly Off-White Powder
Documentation
CoA / DMF / GMP
Direct Procurement Quote
Fill details to receive commercial terms and Certificate of Analysis (CoA).
Technical Specifications Summary
Chemical / Product Name
Pazopanib Multi-Target TKI API
CAS Registry Number
444731-52-6
Standard Grade
Pharma Grade (MW 437.52 g/mol)
Assay / Purity
≥ 98.5% (C21H23N7O2S)
Appearance
White to Slightly Off-White Powder
Formulation & Industry Applications
Renal Cell Carcinoma Tablets
Soft Tissue Sarcoma Regimens
Related Ingredients
Explore complementary ingredients in Oncology APIs Portfolio: